Complex therapy of recurrent vulvovaginal candidiasis in pregnancy
- Authors: Tyutyunnik V.L.1, Kan N.E.1, Tezikov Y.V.2, Lipatov I.S.2, Mikhailova O.I.1, Mirzabekova D.D.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Samara State Medical University, Ministry of Health of Russia
- Issue: No 11 (2023)
- Pages: 150-156
- Section: Exchange of Experience
- URL: https://journals.rcsi.science/0300-9092/article/view/275118
- DOI: https://doi.org/10.18565/aig.2023.259
- ID: 275118
Cite item
Open Access
Access granted
Subscription Access
Abstract
Objective: To analyze the clinical efficacy of combined therapy of vulvovaginal candidiasis in pregnancy.
Materials and methods: The study included 40 women who were pregnant from 13 to 34 weeks with a confirmed diagnosis of vulvovaginal candidiasis. The patients were divided into two equal groups: the main group included the patients who received therapy for vulvovaginal candidiasis with an antifungal drug in combination with the immunomodulatory drug Superlymph and restoration of vaginal flora with probiotics; the control group included the patients who received only antifungal therapy. Efficacy was evaluated on the basis of the analysis of clinical manifestations, microbiological and microscopic examination of vaginal discharge, pro-inflammatory cytokines.
Results: Clinical manifestations were reduced in both groups after receiving the therapy, but four patients from the control group complained of itching and discharge from the genital tract. The frequency of relapses significantly decreased and the duration of remission increased in the main group. After treatment microscopic examination showed a statistically significant decrease in the number of fungi in both groups, and the number of leukocytes and epithelial cells was decreased in the main group. Bacteriological examination revealed complete elimination of the pathogen in the main group, Candida species were isolated in 15% of patients (n=3) in the control group.
Conclusion: Complex therapy of recurrent vulvovaginal candidiasis in pregnant women with antifungal drugs in combination with the immunomodulatory drug Superlymph and probiotics normalized the vaginal microecology, reduced the number of relapses, and did not have a negative impact on maternal and perinatal outcomes.
Full Text
##article.viewOnOriginalSite##About the authors
Victor L. Tyutyunnik
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Author for correspondence.
Email: tioutiounnik@mail.ru
ORCID iD: 0000-0002-5830-5099
SPIN-code: 1963-1359
Scopus Author ID: 56190621500
ResearcherId: B-2364-2015
Professor, MD, PhD, Leading Researcher of the Center for Scientific and Clinical Research
Russian Federation, 117997, Moscow, Ac. Oparina str., 4Natalia E. Kan
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: kan-med@mail.ru
ORCID iD: 0000-0001-5087-5946
SPIN-code: 5378-8437
Scopus Author ID: 57008835600
ResearcherId: B-2370-2015
Professor, MD, PhD, Deputy Director of Science
Russian Federation, 117997, Moscow, Ac. Oparina str., 4Yurii V. Tezikov
Samara State Medical University, Ministry of Health of Russia
Email: yra.75@inbox.ru
ORCID iD: 0000-0002-8946-501X
SPIN-code: 2896-6986
Scopus Author ID: 161372
ResearcherId: С-6187-2018
Professor, MD, PhD, Head of the Department of Obstetrics and Gynecology of the Institute of Clinical Medicine
Russian Federation, 443099, Samara, Chapaevskaya str., 89Igor S. Lipatov
Samara State Medical University, Ministry of Health of Russia
Email: i.lipatoff2012@yandex.ru
ORCID iD: 0000-0001-7277-7431
SPIN-code: 9625-2947
Scopus Author ID: 6603787595
ResearcherId: С-5060-2018
Professor, MD, PhD, Professor at the Department of Obstetrics and Gynecology of the Institute of Clinical Medicine
Russian Federation, 443099, Samara, Chapaevskaya str., 89Olga I. Mikhailova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: omikhaylova@gmail.com
ORCID iD: 0000-0001-7569-8704
PhD, Researcher of the 2nd Obstetric Physiological Department
Russian Federation, 117997, Moscow, Ac. Oparina str., 4Dzhamilia D. Mirzabekova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: Jamilya1705@yandex.ru
ORCID iD: 0000-0002-2391-3334
graduate student
Russian Federation, 117997, Moscow, Ac. Oparina str., 4References
- Nyirjesy P., Brookhart C., Lazenby G., Schwebke J., Sobel J.D. Vulvovaginal candidiasis: а review of the evidence for the 2021 centers for disease control and prevention of sexually transmitted Infections treatment guidelines. Clin. Infect. Dis. 2022; 74 (Suppl_2): 162-8. https://dx.doi.org/1093/cid/ciab1057.
- Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm. Rep. 2021; 70(4): 1-187. https://dx.doi.org/10.15585/mmwr.rr7004a1.
- Хашукоева А.З., Бурденко М.В., Маркова Э.А., Дмитрашко Т.Е. Современные методы преодоления резистентности возбудителей вульвовагинального кандидоза. Акушерство и гинекология. 2022; 2: 102-8. [Khashukoeva A.Z., Burdenko M.V., Markova E.A., Dmitrashko T.E. Overcoming resistance to pathogens of vulvovaginal candidiasis using modern methods. Obstetrics and Gynecology. 2022; (2): 102-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.2.102-108.
- Disha T., Haque F. Prevalence and risk factors of vulvovaginal candidosis during pregnancy: а review. Infect. Dis. Obstet. Gynecol. 2022; 2022: 6195712. https://dx.doi.org/10.1155/2022/6195712.
- Farr A., Effendy I., Frey Tirri B., Hof H., Mayser P., Petricevic L. et al. Guideline: vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses. 2021; 64(6): 583-602. https://dx.doi.org/10.1111/myc.13248.
- Maftei N.M., Arbune M., Georgescu C.V., Elisei A.M., Iancu A.V., Tatu A.L. Vulvovaginal сandidiasis in pregnancy-between sensitivity and resistance to antimycotics. J. Xenobiot. 2023; 13(3): 312-22. https://dx.doi.org/ 10.3390/jox13030023.
- Al-Rusan R.M., Darwazeh A.M.G, Lataifeh I.M. The relationship of сandida colonization of the oral and vaginal mucosae of mothers and oral mucosae of their newborns at birth. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. 2017; 123(4): 459-63. https://dx.doi.org/10.1016/j.oooo.2017.01.003.
- Shroff S. Infectious vaginitis, cervicitis, and pelvic Inflammatory disease. Med. Clin. North. Am. 2023; 107(2): 299-315. https://dx.doi.org/10.1016/ j.mcna.2022.10.009.
- Waikhom S.D., Afeke I., Kwawu G.S., Mbroh H.K., Osei G.Y., Louis B. et al. Prevalence of vulvovaginal candidiasis among pregnant women in the ho municipality, Ghana: species identification and antifungal susceptibility of candida isolates. BMC Pregnancy Childbirth. 2020; 20(1): 266. https://dx.doi.org/10.1186/s12884-020-02963-3.
- Intra J., Sala M.R., Brambilla P, Carcione D., Leoni V. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: а retrospective study over a 20 year-period. J. Mycol. Med. 2022; 32(3): 101278. https://dx.doi.org/0.1016/j.mycmed.2022.101278.
- Ghaddar N., El Roz A., Ghssein G., Ibrahim J.N. Emergence of vulvovaginal candidiasis among lebanese pregnant women: prevalence, risk factors, and species distribution. Infect. Dis. Obstet. Gynecol. 2019; 2019: 5016810. https://dx.doi.org/10.1155/2019/5016810.
- Schuster H.J., de Jonghe B.A., Limpens J., Budding A.E., Painter R.C. Asymptomatic vaginal Candida colonization and adverse pregnancy outcomes including preterm birth: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2020;2(3):100163. https://dx.doi.org/10.1016/ j.ajogmf.2020.100163.
- Satora M., Grunwald A., Zaremba B., Frankowska K., Żak K., Tarkowski R., Kułak K. Treatment of vulvovaginal candidiasis-an overview of guidelines and the latest treatment methods. J. Clin. Med. 2023; 12(16): 5376. https://dx.doi.org/10.3390/jcm12165376.
- Аполихина И.А., Тетерина Т.А., Васильева С.Н. Урогенитальный кандидоз. Акушерство и гинекология. 2021; 12 (Приложение): 15-20. [Apolikhina I.A., Teterina T.A., Vasilyeva S.N. Urogenital candidiasis. Obstetrics and Gynecology. 2021; 12 (Suppl): 15-20. (in Russian)].
- Боровкова Е.И., Залесская С.А., Степанянц И.В. Сравнительная эффективность влагалищного и ректального применения цитокинотерапии у беременных с дисплазией шейки матки. РМЖ. Мать и дитя. 2019; 2(3):173-6. [Borovkova E.I., Zalesskaya S.A., Stepanyants I.V. Comparative efficacy of vaginal and rectal cytokine therapy in pregnant women with cervical dysplasia. Russian Medical Journal. Mother and Child. 2019; 2(3): 173-6. (in Russian)]. https://dx.doi.org/10.32364/2618-8430-2019-2- 3-173-176.
- Тютюнник В.Л., Михайлова О.И., Кан Н.Е., Мирзабекова Д.Д. Комплексная терапия бактериального вагиноза при беременности. Акушерство и гинекология. 2023; 7: 126-32. [Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D. Complex therapy of bacterial vaginosis during pregnancy. Obstetrics and gynecology. 2023; (7): 126-32. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.172.
- Shenoy A., Gottlieb A. Probiotics for oral and vulvovaginal candidiasis: A review. Dermatol. Ther. 2019; 32(4): e12970. https://dx.doi.org/10.1111/dth.12970.
Supplementary files
